Sclerosis: all 3,103 studies
Page 30 of 32. Open to participants first (314), then studies with results posted, then the rest; newest registration first within each.
- RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAMCompletedNCT00457964Phase 1/2
- Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAMCompletedNCT00457808Phase 2
- Non-Invasive Diagnostic and Functional Evaluation of Cardiac Involvement in Patients With Systemic SclerosisStatus unknownNCT00453752
- A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00445172Phase 2/3
- A Study in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00444613Phase 2/3
- Costs, Quality of Life and Functional Outcomes in Veterans Treated for Multiple Sclerosis With Beta-Interferon l-B (Betaseron)CompletedNCT00439257
- Mycophenolate Mofetil in Systemic SclerosisCompletedNCT00433186Phase 1
- Brain Peripheral Benzodiazepine Receptors in Patients With Multiple SclerosisCompletedNCT00432900Phase 1
- The Effect of Levetiracetam (Keppra) on the Treatment of Tremor in Multiple SclerosisCompletedNCT00430599
- Simvastatin as an add-on Treatment to Copaxone for the Treatment of Relapsing Multiple SclerosisWithdrawnNCT00429442Phase 3
- Ambulation Study in Multiple SclerosisCompletedNCT00424359
- Levetiracetam in Central Pain in Multiple Sclerosis(MS)CompletedNCT00423527Phase 4
- Correlation Between Cognitive Functions and MRI in Multiple SclerosisStatus unknownNCT00423111
- Motor-Point Stimulation for Conditioning the Diaphragm of Patients With Amyotrophic Lateral Sclerosis (ALS)Status unknownNCT00420719Not applicable
- Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple SclerosisStatus unknownNCT00411723Phase 1
- The Effect of Memantine on Functional Outcomes and Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00409721Phase 2
- Comparison of Scheimpflug Photos of the Crystalline Lens in Patients Who Have Undergone Vitrectomy Surgery and ControlsCompletedNCT00406263
- Placebo Controlled Study of ONO2506PO in the Presence of Riluzole in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00403104Phase 2
- An fMRI Study of Treatment Optimization Comparing Two Disease Modifying Therapies Used to Treat Relapsing Remitting Multiple SclerosisTerminatedNCT00398528
- G-CSF Treatment for Amyotrophic Lateral Sclerosis: A RCT Study Assessing Clinical ResponseCompletedNCT00397423Phase 2
- Study Of SB-683699 Compared To Placebo In Subjects With Relapsing-Remitting Multiple Sclerosis (MS)CompletedNCT00395317Phase 2
- Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS)CompletedNCT00395200Phase 1/2
- Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple SclerosisCompletedNCT00393588
- fMRI Study of Treatment Recommendations Comparing Recently Diagnosed Multiple Sclerosis (MS) Patients to ControlsCompletedNCT00391352
- BHT-3009 Immunotherapy in Relapsing Remitting Multiple SclerosisCompletedNCT00382629Phase 2
- Multiple Sclerosis and Heavy Progressive Resistance TrainingCompletedNCT00381576Not applicable
- Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Multiple SclerosisCompletedNCT00381264Phase 4
- A Protocol Based Treatment for Early and Severe Systemic Sclerosis With (Anti-CD20), RituximabCompletedNCT00379431Phase 2
- Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma PatientsCompletedNCT00377949
- Clinical Trial of Vitamin E to Treat Muscular Cramps in Patients With ALSCompletedNCT00372879Phase 3
- Development and Evaluation of a New Palliative Care Service for People Severely Affected With Multiple Sclerosis (MS)CompletedNCT00364936Phase 1/2
- Omega-3 Fatty Acid Treatment in Multiple SclerosisCompletedNCT00360906Phase 2/3
- Combination Therapy Selection Trial in Amyotrophic Lateral SclerosisCompletedNCT00355576Phase 2
- Memantine for Disability in Amyotrophic Lateral Sclerosis (MEDALS)CompletedNCT00353665Phase 2/3
- A Study to Evaluate the Effectiveness, Tolerability and Safety of LaquinimodCompletedNCT00349193Phase 2
- Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate UveitisCompletedNCT00344253Phase 3
- Whole Body Vibration Therapy in a Participant With Multiple Sclerosis Related Balance Deficits - A Case StudyCompletedNCT00343590Not applicable
- Fatigue in Multiple Sclerosis: Evaluated With 3 MRI and Transcranial Magnetic StimulationCompletedNCT00342381Phase 2
- Immunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple SclerosisCompletedNCT00342134Phase 2
- Exposure to Neurotoxins as Risk Factors for Amyotrophic Lateral SclerosisCompletedNCT00339976
- Measuring the Balance Improvement on Multiple Sclerosis Patients After a Short Training Period With an APOS (All Phase Of Step Cycle) KitStatus unknownNCT00338637Phase 2
- Effects of Gastrostomy on Amyotrophic Lateral SclerosisCompletedNCT00337402
- Brain Function in Primary Lateral Sclerosis and Amyotrophic Lateral SclerosisCompletedNCT00334516
- Treadmill Training in Chronic MS: Efficacy and Cost-effectivenessWithdrawnNCT00334100Not applicable
- Gait Evaluation in Multiple Sclerosis Patients Treated With Glatiramer AcetateStatus unknownNCT00331747Not applicable
- Biomarkers in Multiple SclerosisCompletedNCT00325988
- Safety and Efficacy of Cellcept and Avonex as Combination Treatment in Multiple SclerosisCompletedNCT00324506Phase 2
- Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron DiseaseCompletedNCT00324454Phase 2
- Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple SclerosisCompletedNCT00321568
- Effect of Bosentan on Skin Fibrosis in Patients With Systemic SclerosisCompletedNCT00318175Phase 2
- Betaseron Pregnancy RegistryCompletedNCT00317564
- A fMRI(Functional Magnetic Resonance Imaging) Research Study to Learn More About Multiple Sclerosis and Individuals Potentially Experiencing Memory DifficultiesCompletedNCT00315367Phase 4
- Study to Compare Double-dose Betaferon to the Approved Dose, for Patients With Early Secondary Progressive Multiple Sclerosis (SPMS)WithdrawnNCT00313976Phase 3
- Amyotrophic Lateral Sclerosis Web Based Patient Care Database: ALSConnection.OrgCompletedNCT00302198
- Trial of Memantine for Cognitive Impairment in Multiple SclerosisCompletedNCT00300716Phase 2/3
- Combination Therapy of Betaseron-Prograf in Multiple SclerosisStatus unknownNCT00298662Phase 2
- Phase II High-Dose Cyclophosphamide for Multiple SclerosisWithdrawnNCT00296205Phase 2
- A Study of Rebif® Compared With Avonex® in the Treatment of Relapsing-remitting Multiple Sclerosis (MS)CompletedNCT00292266Phase 3
- Tolerability of Rebif® Injection With and Without the Use of Rebiject™Mini in Relapsing-Remitting Multiple Sclerosis SubjectsCompletedNCT00292253Phase 3
- Neuropathic Pain Assessment Comparing Pregabalin and Paroxetine in Management of MS-induced Neuropathic PainCompletedNCT00291148Phase 3
- Multimodal MRI in Multiple Sclerosis (MS): Reliability and Follow UpStatus unknownNCT00289159
- A Serologic Study to Correlate Beta-IFN NAb Titers to Beta-IFN Induced Biomarker Response in Patients With Multiple SclerosisCompletedNCT00288990
- Cranberry for Prevention of Urinary Tract Infections in Multiple Sclerosis PatientsCompletedNCT00280592Phase 3
- Study on the Effectiveness of EGb 761® vs Placebo Used for Cognitive Impairment in Patients With Multiple SclerosisCompletedNCT00276341Phase 3
- Open-Label Natalizumab Safety Extension StudyCompletedNCT00276172Phase 3
- Interferon ß-1b Treatment by Cyclical AdministrationCompletedNCT00270816Phase 2/3
- FOCUS Fatigue Outcome in Copaxone USersCompletedNCT00267319Phase 4
- Simvastatin Treatment of Patients With Acute Optic NeuritisStatus unknownNCT00261326Phase 3
- Cannabis for Spasticity in Multiple SclerosisTerminatedNCT00260741Phase 1/2
- A Randomised Controlled Trial of Neuroprotection With Lamotrigine in Secondary Progressive Multiple SclerosisCompletedNCT00257855Phase 2
- Short-Term Effects of Medicinal Cannabis Therapy on Spasticity in Multiple SclerosisCompletedNCT00248378Phase 1/2
- Autologous T Cell Vaccine (TCV) for Multiple SclerosisCompletedNCT00245622Phase 2
- A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALSCompletedNCT00244244Phase 2
- A Safety Study of Combination Treatment With Avonex and Zocor in Relapsing Remitting Multiple SclerosisStatus unknownNCT00242268Phase 3
- Pilot Test of ACTOS in Multiple Sclerosis: Safety and TolerabilityCompletedNCT00242177Phase 1
- Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple SclerosisCompletedNCT00241254Phase 3
- Rapamycin vs Methotrexate in Diffuse SScCompletedNCT00241189Phase 1/2
- A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®.CompletedNCT00240032Phase 4
- A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® AloneCompletedNCT00240006Phase 4
- A Study to Assess the Effects of MK0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by Magnetic Resonance Imaging (MRI)(0812-003)(COMPLETED)TerminatedNCT00239655Phase 2
- Safety/Effectiveness of Adding Monthly Dexamethasone to Weekly Avonex for MSCompletedNCT00232193
- Pilot-Study of Thalidomide in Amyotrophic Lateral Sclerosis (ALS)TerminatedNCT00231140Phase 2
- Infections and Autoimmunity: Autobodies Screening in Multiple SclerosisStatus unknownNCT00230204Phase 1
- A Long-term Extension Study of TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis(ALS)CompletedNCT00230074Phase 2
- Cognitive Effects of Immunomodulatory Drugs in MSCompletedNCT00229502
- Study Evaluating CCI-779 in Relapsing Multiple SclerosisCompletedNCT00228397Phase 2
- TCV -01-002: T-Cell Vaccination in the Treatment of Probable Multiple SclerosisStatus unknownNCT00228228Phase 3
- Long Term Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With RelapsesCompletedNCT00228163Phase 2
- Treatment of Early Systemic Sclerosis by BosentanTerminatedNCT00226889Phase 1/2
- Factors That Influence Compliance With Disease-Modifying Therapy in Multiple SclerosisCompletedNCT00223457
- Safety Study of Combination Therapy With Intramuscular Avonex and Oral Cellcept in Patients With Multiple SclerosisCompletedNCT00223301Phase 2/3
- A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone®.CompletedNCT00220922Phase 4
- Fatigue Treatment Using ProvigilStatus unknownNCT00220506Not applicable
- Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) PatientsStatus unknownNCT00220493Phase 1
- T-Cell Vaccination in Multiple Sclerosis (MS)Status unknownNCT00220428Phase 1/2
- Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple SclerosisTerminatedNCT00219908Phase 2
- A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple SclerosisStatus unknownNCT00217295Phase 2
- Tamoxifen Therapy in Amyotrophic Lateral Sclerosis [ALS]CompletedNCT00214110Phase 2
- A Study of the Expression of Nogo and Reticulon Genes in Skeletal Muscle of Patients With Amyotrophic Lateral SclerosisTerminatedNCT00213824
- An Efficacy and Safety Comparison Study of Two Marketed Drugs in Patients With Relapsing-remitting MSCompletedNCT00206648Phase 4